Volume 64, Issue 3

A Joint Model for Longitudinal Measurements and Survival Data in the Presence of Multiple Failure Types

Robert M. Elashoff

Department of Biostatistics, School of Public Health, University of California at Los Angeles, Los Angeles, California 90095, U.S.A.

Department of Biomathematics, University of California at Los Angeles, 10833 Leconte Avenue, Box 951766, Los Angeles, California 90095‐1766, U.S.A.

Search for more papers by this author
Gang Li

Department of Biostatistics, School of Public Health, University of California at Los Angeles, Los Angeles, California 90095, U.S.A.

Search for more papers by this author
Ning Li

Corresponding Author

Department of Biomathematics, University of California at Los Angeles, 10833 Leconte Avenue, Box 951766, Los Angeles, California 90095‐1766, U.S.A.

email: ningli@ucla.eduSearch for more papers by this author
First published: 18 August 2008
Citations: 93

Abstract

Summary In this article we study a joint model for longitudinal measurements and competing risks survival data. Our joint model provides a flexible approach to handle possible nonignorable missing data in the longitudinal measurements due to dropout. It is also an extension of previous joint models with a single failure type, offering a possible way to model informatively censored events as a competing risk. Our model consists of a linear mixed effects submodel for the longitudinal outcome and a proportional cause‐specific hazards frailty submodel (Prentice et al., 1978, Biometrics34, 541–554) for the competing risks survival data, linked together by some latent random effects. We propose to obtain the maximum likelihood estimates of the parameters by an expectation maximization (EM) algorithm and estimate their standard errors using a profile likelihood method. The developed method works well in our simulation studies and is applied to a clinical trial for the scleroderma lung disease.

Number of times cited according to CrossRef: 93

  • Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model, BMC Infectious Diseases, 10.1186/s12879-020-04972-1, 20, 1, (2020).
  • Competing risks joint models using R-INLA, Statistical Modelling, 10.1177/1471082X19913654, (1471082X1991365), (2020).
  • Joint analysis of longitudinal and interval-censored failure time data, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2020.1770284, (1-17), (2020).
  • Joint models with multiple longitudinal outcomes and a time-to-event outcome: a corrected two-stage approach, Statistics and Computing, 10.1007/s11222-020-09927-9, (2020).
  • Joint Modeling of a Longitudinal Measurement and Parametric Survival Data with Application to Primary Biliary Cirrhosis Study, Pakistan Journal of Statistics and Operation Research, 10.18187/pjsor.v16i2.3131, (295-304), (2020).
  • Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks, Statistical Modelling, 10.1177/1471082X20933363, (1471082X2093336), (2020).
  • On the predictive performance of two Bayesian joint models: a simulation study, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2020.1804579, (1-10), (2020).
  • Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data, Statistical Modelling, 10.1177/1471082X20944620, (1471082X2094462), (2020).
  • Dynamic prediction of competing risk events using landmark sub-distribution hazard model with multiple longitudinal biomarkers, Statistical Methods in Medical Research, 10.1177/0962280220921553, (096228022092155), (2020).
  • An Overview of Joint Modeling of Time-to-Event and Longitudinal Outcomes, Annual Review of Statistics and Its Application, 10.1146/annurev-statistics-030718-105048, 6, 1, (223-240), (2019).
  • The Effect of MSM and CD4+ Count on the Development of Cancer AIDS (AIDS-defining Cancer) and Non-cancer AIDS in the HAART Era, Current HIV Research, 10.2174/1570162X17666181205130532, 16, 4, (288-296), (2019).
  • Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II, The Journal of Rheumatology, 10.3899/jrheum.180441, 46, 10, (1316-1325), (2019).
  • Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time‐to‐event data, Statistics in Medicine, 10.1002/sim.8334, 38, 24, (4804-4818), (2019).
  • A varying‐coefficient generalized odds rate model with time‐varying exposure: An application to fitness and cardiovascular disease mortality, Biometrics, 10.1111/biom.13057, 75, 3, (853-863), (2019).
  • Regression analysis of interval-censored failure time data with time-dependent covariates, Computational Statistics & Data Analysis, 10.1016/j.csda.2019.106848, (106848), (2019).
  • An issue of identifying longitudinal biomarkers for competing risks data with masked causes of failure considering frailties model, Statistical Methods in Medical Research, 10.1177/0962280219842352, (096228021984235), (2019).
  • Quantile regression-based Bayesian joint modeling analysis of longitudinal–survival data, with application to an AIDS cohort study, Lifetime Data Analysis, 10.1007/s10985-019-09478-w, (2019).
  • A Joint modelling of socio-professional trajectories and cause-specific mortality, Computational Statistics & Data Analysis, 10.1016/j.csda.2017.10.002, 119, (39-54), (2018).
  • Recent Developments and Advances in Joint Modelling of Longitudinal and Survival Data, The Mathematics of the Uncertain, 10.1007/978-3-319-73848-2_21, (219-229), (2018).
  • Joint Modelling of Survival and Longitudinal Data with Informative Observation Times, Scandinavian Journal of Statistics, 10.1111/sjos.12314, 45, 3, (571-589), (2018).
  • A comparison of joint models for longitudinal and competing risks data, with application to an epilepsy drug randomized controlled trial, Journal of the Royal Statistical Society: Series A (Statistics in Society), 10.1111/rssa.12348, 181, 4, (1105-1123), (2018).
  • A joint longitudinal and survival model for dynamic treatment regimes in Presence of Competing Risk Analysis, Clinical Epidemiology and Global Health, 10.1016/j.cegh.2018.09.001, (2018).
  • Jointly Modelling Single Nucleotide Polymorphisms With Longitudinal and Time-to-Event Trait: An Application to Type 2 Diabetes and Fasting Plasma Glucose, Frontiers in Genetics, 10.3389/fgene.2018.00210, 9, (2018).
  • Joint Modeling of Multivariate Longitudinal Data and Competing Risks Using Multiphase Sub-models, Statistics in Biosciences, 10.1007/s12561-018-9223-6, (2018).
  • Regularized approach for data missing not at random, Statistical Methods in Medical Research, 10.1177/0962280217717760, 28, 1, (134-150), (2017).
  • A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution, Statistical Methods in Medical Research, 10.1177/0962280217706727, 27, 12, (3577-3594), (2017).
  • Dynamic prediction of mortality among patients in intensive care using the sequential organ failure assessment (SOFA) score: a joint competing risk survival and longitudinal modeling approach, Statistica Neerlandica, 10.1111/stan.12114, 72, 1, (34-47), (2017).
  • Accommodating informative dropout and death: a joint modelling approach for longitudinal and semicompeting risks data, Journal of the Royal Statistical Society: Series C (Applied Statistics), 10.1111/rssc.12210, 67, 1, (145-163), (2017).
  • Bayesian varying coefficient mixed-effects joint models with asymmetry and missingness, Statistical Modelling: An International Journal, 10.1177/1471082X16678543, 17, 3, (117-141), (2017).
  • Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II, Arthritis & Rheumatology, 10.1002/art.40114, 69, 7, (1451-1460), (2017).
  • H‐likelihood approach for joint modeling of longitudinal outcomes and time‐to‐event data, Biometrical Journal, 10.1002/bimj.201600243, 59, 6, (1122-1143), (2017).
  • Two‐stage model for multivariate longitudinal and survival data with application to nephrology research, Biometrical Journal, 10.1002/bimj.201600244, 59, 6, (1204-1220), (2017).
  • Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: A randomized clinical trial, Journal of Clinical Periodontology, 10.1111/jcpe.12763, 44, 8, (833-841), (2017).
  • Penalized Likelihood Approach for Simultaneous Analysis of Survival Time and Binary Longitudinal Outcome, Sankhya B, 10.1007/s13571-017-0132-3, 79, 2, (190-216), (2017).
  • Modeling Longitudinal-Competing Risks Data With Skew Distribution and Mismeasured Covariate, Statistics in Biopharmaceutical Research, 10.1080/19466315.2016.1208624, 9, 1, (73-84), (2017).
  • Simultaneous inference for semiparametric mixed-effects joint models with skew distribution and covariate measurement error for longitudinal competing risks data analysis, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1293080, 27, 6, (1009-1027), (2017).
  • Bayesian Analysis of Joint Modeling of Longitudinal and Time to Event Data Using Some Skew-Elliptical Distributions, Biometrics & Biostatistics International Journal, 10.15406/bbij.2017.05.00153, 5, 6, (2017).
  • Joint modeling of survival time and longitudinal outcomes with flexible random effects, Lifetime Data Analysis, 10.1007/s10985-017-9405-4, (2017).
  • Bayesian joint modeling for assessing the progression of chronic kidney disease in children, Statistical Methods in Medical Research, 10.1177/0962280216628560, 27, 1, (298-311), (2016).
  • Bayesian inference on longitudinal-survival data with multiple features, Computational Statistics, 10.1007/s00180-016-0681-3, 32, 3, (845-866), (2016).
  • Simulated maximum likelihood estimation in joint models for multiple longitudinal markers and recurrent events of multiple types, in the presence of a terminal event, Journal of Applied Statistics, 10.1080/02664763.2016.1262336, 44, 15, (2756-2777), (2016).
  • Joint HGLM approach for repeated measures and survival data, Journal of the Korean Data and Information Science Society, 10.7465/jkdi.2016.27.4.1083, 27, 4, (1083-1090), (2016).
  • Joint models for multiple longitudinal processes and time-to-event outcome, Journal of Statistical Computation and Simulation, 10.1080/00949655.2016.1181760, 86, 18, (3682-3700), (2016).
  • A Bayesian model for joint analysis of multivariate repeated measures and time to event data in crossover trials, Statistical Methods in Medical Research, 10.1177/0962280213519594, 25, 5, (2180-2192), (2016).
  • Survival analysis with functional covariates for partial follow-up studies, Statistical Methods in Medical Research, 10.1177/0962280214523586, 25, 6, (2405-2419), (2016).
  • The Latent Class Stochastic Process Model for Evaluation of Hidden Heterogeneity in Longitudinal Data, Biodemography of Aging, 10.1007/978-94-017-7587-8_13, (285-302), (2016).
  • Joint modeling of HIV data in multicenter observational studies: A comparison among different approaches, Statistical Methods in Medical Research, 10.1177/0962280214526192, 25, 6, (2472-2487), (2016).
  • Joint modelling of longitudinal and multi‐state processes: application to clinical progressions in prostate cancer, Statistics in Medicine, 10.1002/sim.6972, 35, 22, (3933-3948), (2016).
  • Correlated probit analysis of repeatedly measured ordinal and continuous outcomes with application to the Health and Retirement Study, Statistics in Medicine, 10.1002/sim.6982, 35, 23, (4202-4225), (2016).
  • Joint model for left‐censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000–05 trial, Biometrics, 10.1111/biom.12490, 72, 3, (907-916), (2016).
  • Local disinfection with sodium hypochlorite as adjunct to basic periodontal therapy: a randomized controlled trial, Journal of Clinical Periodontology, 10.1111/jcpe.12578, 43, 9, (778-788), (2016).
  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial, The Lancet Respiratory Medicine, 10.1016/S2213-2600(16)30152-7, 4, 9, (708-719), (2016).
  • Joint latent class model for longitudinal data and interval‐censored semi‐competing events: Application to dementia, Biometrics, 10.1111/biom.12530, 72, 4, (1123-1135), (2016).
  • Bayesian nonparametric mixed-effects joint model for longitudinal-competing risks data analysis in presence of multiple data features, Statistical Methods in Medical Research, 10.1177/0962280215597939, 26, 5, (2407-2423), (2015).
  • Joint modeling of recurrent event processes and intermittently observed time-varying binary covariate processes, Lifetime Data Analysis, 10.1007/s10985-014-9316-6, 22, 1, (145-160), (2015).
  • Mixed-effects varying-coefficient model with skewed distribution coupled with cause-specific varying-coefficient hazard model with random-effects for longitudinal-competing risks data analysis, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2015.1052493, 26, 3, (519-533), (2015).
  • Estimating Health Demand for an Aging Population: A Flexible and Robust Bayesian Joint Model, Journal of Applied Econometrics, 10.1002/jae.2463, 31, 6, (1140-1158), (2015).
  • Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach, Statistics in Medicine, 10.1002/sim.6731, 35, 3, (382-398), (2015).
  • Simultaneous inference of a misclassified outcome and competing risks failure time data, Journal of Applied Statistics, 10.1080/02664763.2014.995606, 42, 5, (1080-1090), (2015).
  • Discussion on ‘Joint modeling of survival and longitudinal non‐survival data’ by Gould et al., Statistics in Medicine, 10.1002/sim.6284, 34, 14, (2198-2199), (2015).
  • A joint model for repeated events of different types and multiple longitudinal outcomes with application to a follow‐up study of patients after kidney transplant, Biometrical Journal, 10.1002/bimj.201300167, 57, 2, (185-200), (2014).
  • Identification of Longitudinal Biomarkers in Survival Analysis for Competing Risks Data, Communications in Statistics - Theory and Methods, 10.1080/03610926.2012.716135, 43, 16, (3329-3342), (2014).
  • Semicompeting risks in aging research: methods, issues and needs, Lifetime Data Analysis, 10.1007/s10985-014-9295-7, 20, 4, (538-562), (2014).
  • A joint frailty model to estimate the recurrence process and the disease‐specific mortality process without needing the cause of death, Statistics in Medicine, 10.1002/sim.6140, 33, 18, (3147-3166), (2014).
  • Joint modeling of two longitudinal outcomes and competing risk data, Statistics in Medicine, 10.1002/sim.6158, 33, 18, (3167-3178), (2014).
  • Bayesian Joint Modeling of Longitudinal Measurements and Time-to-Event Data Using Robust Distributions, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2014.903657, 24, 4, (834-855), (2014).
  • Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data, Journal of Applied Statistics, 10.1080/02664763.2014.909789, 41, 10, (2270-2281), (2014).
  • Joint Analysis of Survival Time and Longitudinal Categorical Outcomes, Statistics in Biosciences, 10.1007/s12561-013-9091-z, 7, 1, (19-47), (2013).
  • Estimation of the treatment effect in the presence of non‐compliance and missing data, Statistics in Medicine, 10.1002/sim.5924, 33, 2, (193-208), (2013).
  • Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD, Respiratory Medicine, 10.1016/j.rmed.2013.08.001, 107, 12, (1904-1911), (2013).
  • Joint Modeling of Longitudinal and Time-to-Event Data: Challenges and Future Directions, Advances in Theoretical and Applied Statistics, 10.1007/978-3-642-35588-2, (199-209), (2013).
  • Regression Analysis of Panel Count Data II, Statistical Analysis of Panel Count Data, 10.1007/978-1-4614-8715-9_6, (121-153), (2013).
  • Longitudinal data analysis with non-ignorable missing data, Statistical Methods in Medical Research, 10.1177/0962280212448721, 25, 1, (205-220), (2012).
  • An exploration of fixed and random effects selection for longitudinal binary outcomes in the presence of nonignorable dropout, Biometrical Journal, 10.1002/bimj.201100107, 55, 1, (17-37), (2012).
  • Fast fitting of joint models for longitudinal and event time data using a pseudo-adaptive Gaussian quadrature rule, Computational Statistics & Data Analysis, 10.1016/j.csda.2011.09.007, 56, 3, (491-501), (2012).
  • Bayesian inference of the fully specified subdistribution model for survival data with competing risks, Lifetime Data Analysis, 10.1007/s10985-012-9221-9, 18, 3, (339-363), (2012).
  • Bibliography, Joint Models for Longitudinal and Time-to-Event Data, 10.1201/b12208-12, (239-255), (2012).
  • Cost-Effectiveness Comparison of Response Strategies to a Large-Scale Anthrax Attack on the Chicago Metropolitan Area: Impact of Timing and Surge Capacity, Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 10.1089/bsp.2011.0105, 10, 3, (264-279), (2012).
  • Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects, Statistics in Medicine, 10.1002/sim.4507, 31, 16, (1707-1721), (2012).
  • Joint model with latent state for longitudinal and multistate data, Biostatistics, 10.1093/biostatistics/kxr003, 12, 4, (723-736), (2011).
  • Comparison of imputation methods for interval censored time‐to‐event data in joint modelling of tree growth and mortality, Canadian Journal of Statistics, 10.1002/cjs.10119, 39, 3, (438-457), (2011).
  • A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time‐to‐event, Statistics in Medicine, 10.1002/sim.4205, 30, 12, (1366-1380), (2011).
  • Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time‐to‐Event Data, Biometrics, 10.1111/j.1541-0420.2010.01546.x, 67, 3, (819-829), (2011).
  • Joint Modeling of Multiple Longitudinal Patient-Reported Outcomes and Survival, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2011.590922, 21, 5, (971-991), (2011).
  • A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects, Lifetime Data Analysis, 10.1007/s10985-010-9169-6, 17, 1, (80-100), (2010).
  • Joint modeling of longitudinal data and informative dropout time in the presence of multiple changepoints, Statistics in Medicine, 10.1002/sim.4119, 30, 6, (611-626), (2010).
  • Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data, BMC Medical Research Methodology, 10.1186/1471-2288-10-69, 10, 1, (2010).
  • Random Effects Models for Longitudinal Data, Longitudinal Research with Latent Variables, 10.1007/978-3-642-11760-2, (37-96), (2010).
  • Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt‐PA stroke trial, Statistics in Medicine, 10.1002/sim.3798, 29, 5, (546-557), (2009).
  • Multiple‐Imputation‐Based Residuals and Diagnostic Plots for Joint Models of Longitudinal and Survival Outcomes, Biometrics, 10.1111/j.1541-0420.2009.01273.x, 66, 1, (20-29), (2009).
  • Robust Joint Modeling of Longitudinal Measurements and Competing Risks Failure Time Data, Biometrical Journal, 10.1002/bimj.200810491, 51, 1, (19-30), (2009).
  • Simulating competing risks data in survival analysis, Statistics in Medicine, 10.1002/sim.3516, 28, 6, (956-971), (2009).
  • A Bayesian approach to joint analysis of longitudinal measurements and competing risks failure time data, Statistics in Medicine, 10.1002/sim.3562, 28, 11, (1601-1619), (2009).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.